Anthony J Gill is Professor of Surgical Pathology at the University of Sydney and a senior staff specialist in anatomical pathology at the Royal North Shore Hospital. Anthony has a keen interest in the application of innovative diagnostic pathology techniques in translational cancer research with particular emphasis on cancer biomarker discovery and validation.
He has published extensively in hereditary cancer syndromes as well as endocrine, gastrointestinal and hepatobiliary pathology, and is an internationally recognised expert on hereditary cancers which arise due to defects in oxidative respiration (so called “SDH deficient” neoplasms).
Anthony is a Chief Investigator at the Kolling Institute and a member of the executive board of the Sydney Vital Translational Cancer Research Unit. He is also chairman of the Australian Pancreatic Cancer Genome Initiative at the Garvan Institute, an award winning collaborative initiative of cancer healthcare professionals including surgeons, oncologists, nurses, scientists and ethicists.
In addition to over 300 original research publications, Anthony has co-authored 10 WHO blue book chapters across three volumes (urological, head and neck and endocrine) and is a standing member of the Editorial Board for the upcoming 5th edition of the WHO blue book series.
Created on Adobe Muse. All designs and images are the intellectual property of CaDxPath. 2017.